Learn about the global antibody drug conjugates market through The Business Research Company, which provides information on antibody drug conjugates market size, antibody drug conjugates market drivers and restraints, antibody drug conjugates market players, the COVID-19 impact on the antibody drug conjugates market, and more.

The global antibody drug conjugates market size is expected to grow from $4.79 billion in 2021 to $5.90 billion in 2022 at a compound annual growth rate (CAGR) of 23.1%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The antibody drug conjugates market is expected to reach $13.06 billion in 2026 at a CAGR of 22%.

The antibody drug conjugates market is being driven by rising incidences of cancer globally.

Request A Sample For The Global Antibody Drug Conjugates Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2569&type=smp

The antibody-drug conjugates (ADCs) market consists of sales of antibody-drug conjugates. Antibody-drug conjugates are complex engineered therapeutics consisting of monoclonal antibodies, directed toward tumor-associated antigens, to which highly potent cytotoxic agents are attached using chemical linkers.

Global Antibody Drug Conjugates Market Segments Include:

By Type: Monoclonal Antibodies, Linker, Drug/Toxin, Others

By Application: Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain Tumor, Others

By Product: Adcertis, Kadcyla, Others

By Technology: Immunogen Technology, Seattle Genetics Technology, Immunomedics Technology, Others

By End-User: Hospital, Clinics, Others

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the antibody-drug conjugates (ADCs) market in 2021.

Manufacturers of antibody drug conjugates are increasingly collaborating or partnering with other companies to share technology, resources, product knowledge and expand business.

TBRC’s antibody drug conjugates market report covers:

Major Market Players: Bayer AG, Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., Immunomedics Inc., Oxford BioTherapeutics, Pfizer Inc., Seattle GeneticsInc., Takeda Pharmaceutical Company Limited, Abbvie Inc. and Astellas Pharma/Agensys.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)

The Antibody Drug Conjugates Global Market Report 2022–Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides antibody drug conjugates market overviews, analyses and forecasts market size, share, antibody drug conjugates market players, antibody drug conjugates market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s antibody drug conjugates market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports From The Business Research Company:

Conjugated Monoclonal Antibodies Global Market Report 2022

Monoclonal Antibodies (MAbs) Global Market Report 2022

Brain Tumor Drugs Market 2022

Interested To Know More About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: